These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6412267)

  • 1. D-amphetamine in obsessive-compulsive disorder.
    Insel TR; Hamilton JA; Guttmacher LB; Murphy DL
    Psychopharmacology (Berl); 1983; 80(3):231-5. PubMed ID: 6412267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder.
    Koran LM; Aboujaoude E; Gamel NN
    J Clin Psychiatry; 2009 Nov; 70(11):1530-5. PubMed ID: 19573497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE
    J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.
    Fallon BA; Liebowitz MR; Campeas R; Schneier FR; Marshall R; Davies S; Goetz D; Klein DF
    Arch Gen Psychiatry; 1998 Oct; 55(10):918-24. PubMed ID: 9783563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvoxamine treatment of obsessive-compulsive disorder.
    Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R
    Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
    Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.
    Thorén P; Asberg M; Cronholm B; Jörnestedt L; Träskman L
    Arch Gen Psychiatry; 1980 Nov; 37(11):1281-5. PubMed ID: 7436690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.
    Gordon CT; State RC; Nelson JE; Hamburger SD; Rapoport JL
    Arch Gen Psychiatry; 1993 Jun; 50(6):441-7. PubMed ID: 8498878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
    Jenike MA; Baer L; Summergrad P; Weilburg JB; Holland A; Seymour R
    Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
    Insel TR; Murphy DL; Cohen RM; Alterman I; Kilts C; Linnoila M
    Arch Gen Psychiatry; 1983 Jun; 40(6):605-12. PubMed ID: 6342562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL
    Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    Leonard HL; Swedo SE; Rapoport JL; Koby EV; Lenane MC; Cheslow DL; Hamburger SD
    Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
    Hoehn-Saric R; McLeod DR; Zimmerli WD; Hipsley PA
    J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
    McDougle CJ; Goodman WK; Leckman JF; Lee NC; Heninger GR; Price LH
    Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
    Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
    Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.
    Goodman WK; Price LH; Rasmussen SA; Delgado PL; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1989 Jan; 46(1):36-44. PubMed ID: 2491940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
    Hewlett WA; Vinogradov S; Agras WS
    J Clin Psychopharmacol; 1992 Dec; 12(6):420-30. PubMed ID: 1474179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
    Pato MT; Pigott TA; Hill JL; Grover GN; Bernstein S; Murphy DL
    Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder.
    Tollefson GD; Rampey AH; Potvin JH; Jenike MA; Rush AJ; kominguez RA; Koran LM; Shear MK; Goodman W; Genduso LA
    Arch Gen Psychiatry; 1994 Jul; 51(7):559-67. PubMed ID: 8031229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.